iBio Establishes Strategic Commercial Relationship with CC-Pharming Ltd. of Beijing, China
July 9, 2018
NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) — iBio, Inc. (NYSE AMERICAN:IBIO) today announced the commencement of a strategic commercial relationship with CC-Pharming Ltd. of Beijing, China for joint development of products and manufacturing facilities for the Chinese biopharmaceutical market, utilizing iBio’s technology. The first product focus selected pursuant to the Master Joint Development Agreement …